BHF researchers secure EU approval for new AI heart attack prediction technology
Research funded by us has led to EU-approved artificial intelligence (AI) technology that can identify people at high risk of a fatal heart attack years before it strikes.
The first-of-its-kind technology, CaRi-Heart®, was developed by spinout company Caristo Diagnostics and has the power to detect ‘invisible’ risk in people with possible heart disease by using routine heart scans already performed in clinical practice. CaRi-Heart® has now received it’s CE mark accreditation, meaning it can be used by doctors across the UK and Europe, and can be rolled out across the NHS.
You can read the full article here.
American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…
British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day
Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…